# FDA Inspection 1265444 - BioEclipse Therapeutics, Inc. - March 25, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/bioeclipse-therapeutics-inc/dc212f11-2dc0-4d60-835a-d37928abaaa0
Source feed: FDA_Inspections

> FDA Inspection 1265444 for BioEclipse Therapeutics, Inc. on March 25, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265444
- Company Name: BioEclipse Therapeutics, Inc.
- Inspection Date: 2025-03-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: San Francisco District Office

## Related Documents

- [FDA Inspection 1265444 - 2025-03-25](https://www.globalkeysolutions.net/records/fda_inspections/bioeclipse-therapeutics-inc/164abb15-ec65-4e41-a873-d3da068de8fa)

Company: https://www.globalkeysolutions.net/companies/bioeclipse-therapeutics-inc/9261c9df-d246-4115-a7ed-e660834bd635

Office: https://www.globalkeysolutions.net/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df